As HIV continues to be prevalent, key ingredients of antiretroviral medicines have been altered in the last few decades. Earlier the treatment specified by doctors tackled the malignancies and infections arising in the patient. With the advent of new formulations, the focus has shifted towards low CD4 counts. Various trials have been conducted since 1987 …
Continue reading “Are Antiretroviral medicines the only critical lifeline for HIV/AIDS?”